A Study of rSIFN-co in Subjects With Advanced Solid Tumors

Clinical trial NCT02387307 · COMPLETED

Trial details

NCT number: NCT02387307
Sponsor: Sichuan Huiyang Life Science and Technology Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Melanoma Carcinoma, Hepatocellular Colon Cancer

Start date: 2013-07-01
Primary completion: 2018-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.